Replacing Low-Value Hormonal and Symptom-Only Treatments with Evidence-Based, Hormone-Free Women’s Health Care

Fempharma addresses low-value care in women’s health, where symptom-only or hormone-based interventions are often used despite limited long-term benefit, contraindications, or patient preference.

Examples include:

• Repeated antifungal use for rVVC without prevention

• Hormone therapy where non-hormonal options are preferred or required

• Lack of structured postpartum pelvic-floor recovery pathways

Fempharma’s products offer validated, preventive, and patient-centred alternatives that reduce overtreatment, recurrence, and healthcare utilisation.

Relevance to the call

• Clear low-value care replacement

• Cost-effectiveness potential

• Patient-centred and preference-sensitive care

• Evidence-based decision support

Role in consortium

• SME innovation case provider

• Contribution to value-based care models

• Data for health-economic evaluation

• Dissemination and policy translation